The FDA accepted the Anaphylm NDA resubmission as a class 2 response, setting a March 16, 2027, PDUFA date for the sublingual epinephrine film.
|Articles|November 1, 2012
Ten-week-old boy presents with multiple brown spots
The mother of a healthy 10-week-old boy brings him to your office for evaluation of multiple brown spots on his skin. She noticed the first when he was 2 months old, and other spots have developed on his arms, back, and legs. She has been on the internet and wants to know whether he could have neurologic complications.
Advertisement
Advertisement
Related to this article
Children with FASD given choline before age 6 had 9.1% higher nonverbal IQ and 11.3% better working memory vs placebo 5 years after treatment.
A deep learning model reading 1 nondilated fundus photo predicted 1-year progression to high myopia in children with AUCs of 0.91-0.96.
Todd Wolynn, MD, MMM, FAAP, explains how pediatricians can address misinformation through empathetic communication and community engagement.
SUID was the largest single contributor to the Black-White infant mortality gap in 2024 and drove the biggest share of its rise since 2020.
Nationwide Children's experts urge early screening and family-based lifestyle change as youth-onset T2D progresses faster than adult disease.
A teen’s track collapse reveals CPVT, a hidden inherited arrhythmia; rapid CPR/AED response and family cascade screening prevent sudden cardiac arrest across generations.
Poison center reports of intentional school exposures rose 287% in elementary and 112% in middle school children from 2000 to 2024.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
AI fundus model predicts 1-year high myopia progression in children
2
When one young athlete’s cardiac arrest revealed a family at risk
3
FDA sets new PDUFA date for Anaphylm for type I allergic reactions
4
SUID drives widening Black-White infant mortality gap since 2020
5